These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30610455)

  • 21. A strategy to achieve CRT response in permanent atrial fibrillation without obligatory atrioventricular node ablation.
    Himmel F; Reppel M; Mortensen K; Schunkert H; Bode F
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):943-7. PubMed ID: 22650352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy.
    Dong K; Shen WK; Powell BD; Dong YX; Rea RF; Friedman PA; Hodge DO; Wiste HJ; Webster T; Hayes DL; Cha YM
    Heart Rhythm; 2010 Sep; 7(9):1240-5. PubMed ID: 20156595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    Schütte F; Lüdorff G; Grove R; Kranig W; Thale J
    Cardiol J; 2009; 16(3):246-9. PubMed ID: 19437399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapy.
    Jacobsson J; Reitan C; Carlson J; Borgquist R; Platonov PG
    BMC Cardiovasc Disord; 2019 Aug; 19(1):195. PubMed ID: 31409276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation.
    Rapacciuolo A; Iacopino S; D'Onofrio A; Curnis A; Pisanò EC; Biffi M; Della Bella P; Dello Russo A; Caravati F; Zanotto G; Calvi V; Rovaris G; Senatore G; Nicolis D; Santamaria M; Giammaria M; Maglia G; Duca A; Ammirati G; Romano SA; Piacenti M; Celentano E; Bisignani G; Vaccaro P; Miracapillo G; Bertini M; Nigro G; Giacopelli D; Gargaro A; Bisceglia C
    ESC Heart Fail; 2021 Dec; 8(6):5204-5212. PubMed ID: 34514741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial Fibrillation During Cardiac Resynchronization Therapy.
    Kloosterman M; Maass AH; Rienstra M; Van Gelder IC
    Heart Fail Clin; 2017 Jan; 13(1):179-192. PubMed ID: 27886922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Post hoc analysis on rhythm and high intensity interval training in cardiac resynchronization therapy.
    Melo X; Abreu A; Santos V; Cunha P; Oliveira M; Pinto R; Carmo M; Fernhall B; Santa-Clara H
    Scand Cardiovasc J; 2019 Aug; 53(4):197-205. PubMed ID: 31221002
    [No Abstract]   [Full Text] [Related]  

  • 28. No effects of cardiac resynchronization therapy and right ventricular pacing on the right ventricle in patients with heart failure and atrial fibrillation.
    Majos-Karwacka E; Kraska A; Kowalik I; Smolis-Bak E; Lipiec P; Kasprzak J; Szwed H; Dabrowski R
    Scand Cardiovasc J; 2021 Feb; 55(1):15-21. PubMed ID: 32954833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
    Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
    Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
    Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac resynchronization therapy in patients with atrial fibrillation: a meta-analysis.
    Lopes C; Pereira T; Barra S
    Rev Port Cardiol; 2014 Nov; 33(11):717-25. PubMed ID: 25457476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response.
    Hwang JK; Gwag HB; Park KM; On YK; Kim JS; Park SJ
    PLoS One; 2019; 14(1):e0210603. PubMed ID: 30633768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.
    Stavrakis S; Garabelli P; Reynolds DW
    Europace; 2012 Oct; 14(10):1490-7. PubMed ID: 22696519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes: Effect on mortality and atrial fibrillation incidence.
    Singh JP; Cha YM; Lunati M; Chung ES; Li S; Smeets P; O'Donnell D
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):825-833. PubMed ID: 32009263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Heart Failure From Transient Atrial Fibrillation Attacks in Responders to Cardiac Resynchronization Therapy.
    Nakajima I; Noda T; Kanzaski H; Kamakura T; Wada M; Ishibashi K; Inoue Y; Miyamoto K; Okamura H; Nagase S; Aiba T; Kamakura S; Noguchi T; Yasuda S; Akashi YJ; Kusano KF
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1227-1234. PubMed ID: 30236398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac resynchronization therapy in patients with permanent atrial fibrillation. Is it mandatory to ablate the atrioventricular junction to obtain a good response?
    Tolosana JM; Arnau AM; Madrid AH; Macias A; Lozano IF; Osca J; Quesada A; Toquero J; Francés RM; Bolao IG; Berruezo A; Sitges M; Alcalá MG; Brugada J; Mont L;
    Eur J Heart Fail; 2012 Jun; 14(6):635-41. PubMed ID: 22396459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
    van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of New-Onset Atrial Fibrillation in Patients Receiving CRT: Mechanistic Insights From Speckle Tracking Imaging.
    Sade LE; Atar I; Özin B; Yüce D; Müderrisoğlu H
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):99-111. PubMed ID: 26684972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.